Related Experiment Video
Updated: Feb 7, 2026
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to
Elizabeth Gunn1, Pablo A Angulo2, Sherif M Badawy3
1Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, GA.
Insights
A clinical care pathway improved adherence to pediatric immune thrombocytopenia (ITP) guidelines, reducing medication overuse and hospitalizations. This quality improvement initiative demonstrated feasibility across multiple centers for this rare blood disorder.
Area of Science:
- Hematology
- Pediatrics
- Quality Improvement
Background:
- Practice variation in managing newly diagnosed pediatric immune thrombocytopenia (ITP) persists despite evidence-based guidelines.
- Current management often relies on platelet count, leading to medication overuse and increased hospitalizations.
- The American Society of Hematology (ASH) guidelines recommend symptom-based treatment and short corticosteroid courses.
Purpose of the Study:
- To enhance adherence to ASH ITP guidelines through a multicenter quality improvement initiative.
- To evaluate the impact of a clinical care pathway on the management of pediatric ITP.
Main Methods:
- Implementation of a clinical care pathway by the ITP Consortium of North America across multiple centers.
- Retrospective comparison of pre-implementation (n=284) and post-implementation (n=266) data.
- Assessment of guideline adherence metrics, including bleeding score documentation and medication use.
Main Results:
- Documentation of bleeding scores increased significantly from 1% to 95% post-implementation.
- Initial ITP-directed medication use decreased in children with no/mild bleeding symptoms (62% vs. 31%).
- Intravenous immunoglobulin (IVIG) use reduced substantially from 51% to 15%.
Conclusions:
- Implementation of a clinical care pathway effectively increased adherence to evidence-based ITP guidelines.
- The pathway reduced unnecessary medication use and IVIG administration without compromising clinical outcomes.
- Clinical care pathways are feasible for improving rare disease management across multiple institutions.
Abstract:
Practice variation exists in the management of newly diagnosed pediatric immune thrombocytopenia (ITP) despite the availability of evidence-based treatment guidelines. The American Society of Hematology (ASH) ITP guidelines recommend that the initial treatment of children should be based on an assessment of clinical symptoms rather than the degree of thrombocytopenia and that short courses of corticosteroids should be prescribed to children requiring initial medication treatment. Retrospective review evaluating the treatment of newly diagnosed children with ITP has demonstrated that management continues to be based on the platelet count, with high use of IV immunoglobulin, which results in overuse of medications and high rates of inpatient hospitalizations and medical visits for the administration and management of side effects. To improve adherence to ASH guidelines, the ITP Consortium of North America implemented a clinical care pathway as a multicenter quality improvement initiative. Retrospective data (11 centers; n = 284) were collected before implementation and compared to postimplementation data (12 centers; n = 266). With implementation of the clinical pathway, documentation of a bleeding score for children at diagnosis increased from 1% (3/284) to 95% (253/266). At diagnosis, initial treatment with ITP-directed medications decreased in children with no or mild bleeding symptoms (62% [177/284] vs 31% [83/266]; P< .0001). IV immunoglobulin use reduced from 51% (145/284) to 15% (41/266; P< .0001). With implementation of the pathway, clinical outcomes were comparable with no increase in inpatient hospitalizations or bleeding events. Implementation of a clinical care pathway for a rare condition increases adherence to evidence-based guidelines and is feasible to implement across multiple centers.
Related Concept Videos
02:33Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
02:33Initiation of Translation
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:30Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
01:23Guidelines for Sketching a Curve
01:26Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.